Cargando…
A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications
Epstein-Barr virus (EBV), a double-stranded DNA virus belonging to the family Herpesviridae, infects more than 95% of healthy adults by attacking the host immune system. Here, a novel detection protocol, utilizing the modified multiple cross displacement amplification (MCDA) technique combined with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598869/ https://www.ncbi.nlm.nih.gov/pubmed/37886077 http://dx.doi.org/10.3389/fmicb.2023.1268572 |
_version_ | 1785125649954897920 |
---|---|
author | Zeng, Xiaoyan Yang, Xinggui Yang, Ludi Yi, Xu Chen, Xu Huang, Junfei Wang, Yu Li, Shijun |
author_facet | Zeng, Xiaoyan Yang, Xinggui Yang, Ludi Yi, Xu Chen, Xu Huang, Junfei Wang, Yu Li, Shijun |
author_sort | Zeng, Xiaoyan |
collection | PubMed |
description | Epstein-Barr virus (EBV), a double-stranded DNA virus belonging to the family Herpesviridae, infects more than 95% of healthy adults by attacking the host immune system. Here, a novel detection protocol, utilizing the modified multiple cross displacement amplification (MCDA) technique combined with a gold nanoparticles-based lateral flow biosensors (AuNPs-LFB), was devised and developed to detect EBV infection (termed EBV-MCDA-LFB assay). Ten MCDA primers targeting the EBNA-LP gene were designed, including CP1* primers modified with 6-carboxyfluorescein (FAM) and D1* primers modified with biotin. Then, nucleic acid templates extracted from various pathogens and whole blood samples were used to optimize and evaluate the EBV-MCDA-LFB assay. As a result, the lowest concentration of EBNA-plasmids, which can be detected by MCDA-LFB assay with an optimal reaction condition of 67°C for 30 min, was 10 copies/reaction. Here, the MCDA-LFB assay can detect all EBV pathogens used in the study, and no cross-reactions with non-EBV organisms were observed. Meanwhile, the entire detection workflow of the EBV-MCDA-LFB assay for whole blood samples, including DNA template preparation (25 min), EBV-MCDA amplification (30 min), and AuNPs-LFB-mediated validation (2–5 min), can be completed within 1 h. Taken together, the EBV-MCDA-LFB assay established in the current study is a rapid, simplified, sensitive, specific, and easy-to-obtain technique that can be used as a screening or diagnostic tool for EBV infection in clinical applications, especially in resource-poor regions. |
format | Online Article Text |
id | pubmed-10598869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105988692023-10-26 A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications Zeng, Xiaoyan Yang, Xinggui Yang, Ludi Yi, Xu Chen, Xu Huang, Junfei Wang, Yu Li, Shijun Front Microbiol Microbiology Epstein-Barr virus (EBV), a double-stranded DNA virus belonging to the family Herpesviridae, infects more than 95% of healthy adults by attacking the host immune system. Here, a novel detection protocol, utilizing the modified multiple cross displacement amplification (MCDA) technique combined with a gold nanoparticles-based lateral flow biosensors (AuNPs-LFB), was devised and developed to detect EBV infection (termed EBV-MCDA-LFB assay). Ten MCDA primers targeting the EBNA-LP gene were designed, including CP1* primers modified with 6-carboxyfluorescein (FAM) and D1* primers modified with biotin. Then, nucleic acid templates extracted from various pathogens and whole blood samples were used to optimize and evaluate the EBV-MCDA-LFB assay. As a result, the lowest concentration of EBNA-plasmids, which can be detected by MCDA-LFB assay with an optimal reaction condition of 67°C for 30 min, was 10 copies/reaction. Here, the MCDA-LFB assay can detect all EBV pathogens used in the study, and no cross-reactions with non-EBV organisms were observed. Meanwhile, the entire detection workflow of the EBV-MCDA-LFB assay for whole blood samples, including DNA template preparation (25 min), EBV-MCDA amplification (30 min), and AuNPs-LFB-mediated validation (2–5 min), can be completed within 1 h. Taken together, the EBV-MCDA-LFB assay established in the current study is a rapid, simplified, sensitive, specific, and easy-to-obtain technique that can be used as a screening or diagnostic tool for EBV infection in clinical applications, especially in resource-poor regions. Frontiers Media S.A. 2023-10-11 /pmc/articles/PMC10598869/ /pubmed/37886077 http://dx.doi.org/10.3389/fmicb.2023.1268572 Text en Copyright © 2023 Zeng, Yang, Yang, Yi, Chen, Huang, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Zeng, Xiaoyan Yang, Xinggui Yang, Ludi Yi, Xu Chen, Xu Huang, Junfei Wang, Yu Li, Shijun A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications |
title | A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications |
title_full | A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications |
title_fullStr | A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications |
title_full_unstemmed | A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications |
title_short | A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications |
title_sort | modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of epstein-barr virus in clinical applications |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598869/ https://www.ncbi.nlm.nih.gov/pubmed/37886077 http://dx.doi.org/10.3389/fmicb.2023.1268572 |
work_keys_str_mv | AT zengxiaoyan amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT yangxinggui amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT yangludi amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT yixu amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT chenxu amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT huangjunfei amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT wangyu amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT lishijun amodifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT zengxiaoyan modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT yangxinggui modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT yangludi modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT yixu modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT chenxu modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT huangjunfei modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT wangyu modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications AT lishijun modifiedmultiplecrossdisplacementamplificationlinkedwithagoldnanoparticlebiosensorforthedetectionofepsteinbarrvirusinclinicalapplications |